Related Experiment Video
Updated: Mar 6, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting
Kiyotaka Yoh1, Yasushi Goto2, Yoichi Naito3
1Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan kyoh@east.ncc.go.jp.
Background:
The purpose of this study was to explore the role of maintenance therapy for patients with advanced non-small cell lung cancer (NSCLC) in a real-world setting.
Patients And Methods:
This was a prospective observational cohort multicenter study. Eligible patients were observed from initiation of first-line platinum-based chemotherapy until final follow-up.
Results:
Between 2010 and 2011, a total of 864 patients were enrolled in this study. The primary study population was 396 patients who had progressive disease during observation after first-line chemotherapy without maintenance. Of these, 113 patients (29%) did not receive second-line therapy. In contrast, only 18% of patients who had progressive disease during maintenance therapy missed second-line therapy. Overall survival of patients without maintenance who received second-line therapy was similar to that of those who received maintenance, but no second-line therapy.
Conclusion:
Maintenance therapy for patients with advanced NSCLC might be an appropriate strategy to maximize the chance of receiving more active therapy.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Treatment Resistant Cancers
Therapeutic Drug Monitoring: Affecting Factors
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment